Literature DB >> 21810537

The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering.

Maelene L Wong1, J Kent Leach, Kyriacos A Athanasiou, Leigh G Griffiths.   

Abstract

Decellularization techniques have been developed in an attempt to reduce the antigenicity of xenogeneic biomaterials, a critical barrier in their use as tissue engineering scaffolds. However, numerous studies have demonstrated inadequate removal and subsequent persistence of antigens in the biomaterial following decellularization, resulting in an immune response upon implantation. Thus, methods to enhance antigen removal (AR) are critical for the use of xenogeneic biomaterials in tissue engineering and regenerative medicine. In the present study, AR methods incorporating protein solubilization principles were investigated for their ability to reduce antigenicity of bovine pericardium (BP) for heart valve tissue engineering. Bovine pericardium following AR (BP-AR) was assessed for residual antigenicity, tensile properties, and extracellular matrix composition. Increasing protein solubility during AR significantly decreased the residual antigenicity of BP-AR-by an additional 80% compared to hypotonic solution or 60% compared to 0.1% (w/v) SDS decellularization methods. Moreover, solubilizing agents have a dominant effect on reducing the level of residual antigenicity of BP-AR beyond that achieved by AR additives alone. Tested AR methods did not compromise the tensile properties of BP-AR compared to native BP. Furthermore, residual cell nuclei did not correlate to residual antigenicity, demonstrating that residual nuclei counts may not be an appropriate indicator of successful AR. In conclusion, AR strategies promoting protein solubilization significantly reduced residual antigens compared to decellularization methods without compromising biomaterial functional properties. This study demonstrates the importance of solubilizing protein antigens for their removal in the generation of xenogeneic scaffolds. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810537     DOI: 10.1016/j.biomaterials.2011.07.030

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  23 in total

1.  Graft-specific immune tolerance is determined by residual antigenicity of xenogeneic extracellular matrix scaffolds.

Authors:  Ailsa J Dalgliesh; Mojtaba Parvizi; Manuela Lopera-Higuita; Jeny Shklover; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2018-08-18       Impact factor: 8.947

2.  Nondestructive assessment of collagen hydrogel cross-linking using time-resolved autofluorescence imaging.

Authors:  Benjamin E Sherlock; Jenna N Harvestine; Debika Mitra; Anne Haudenschild; Jerry Hu; Kyriacos A Athanasiou; J Kent Leach; Laura Marcu
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

3.  Remineralized bone matrix as a scaffold for bone tissue engineering.

Authors:  Matthew A Soicher; Blaine A Christiansen; Susan M Stover; J Kent Leach; Clare E Yellowley; Leigh G Griffiths; David P Fyhrie
Journal:  J Biomed Mater Res A       Date:  2014-02-26       Impact factor: 4.396

4.  Effects of biologic scaffolds on human stem cells and implications for CNS tissue engineering.

Authors:  Peter M Crapo; Stephen Tottey; Peter F Slivka; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2013-10-10       Impact factor: 3.845

5.  Effect of Urea and Thiourea on Generation of Xenogeneic Extracellular Matrix Scaffolds for Tissue Engineering.

Authors:  Maelene L Wong; Janelle L Wong; Rebecca M Horn; Kimberley C Sannajust; Dawn A Rice; Leigh G Griffiths
Journal:  Tissue Eng Part C Methods       Date:  2016-06-27       Impact factor: 3.056

Review 6.  The bioactivity of cartilage extracellular matrix in articular cartilage regeneration.

Authors:  Amanda J Sutherland; Gabriel L Converse; Richard A Hopkins; Michael S Detamore
Journal:  Adv Healthc Mater       Date:  2014-07-17       Impact factor: 9.933

7.  Chronic graft-specific cell-mediated immune response toward candidate xenogeneic biomaterial.

Authors:  Katherine V Gates; Leigh G Griffiths
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

Review 8.  Immunogenicity in xenogeneic scaffold generation: antigen removal vs. decellularization.

Authors:  Maelene L Wong; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2014-01-31       Impact factor: 8.947

9.  Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2020-03-07       Impact factor: 8.947

10.  In vivo xenogeneic scaffold fate is determined by residual antigenicity and extracellular matrix preservation.

Authors:  Maelene L Wong; Janelle L Wong; Natalia Vapniarsky; Leigh G Griffiths
Journal:  Biomaterials       Date:  2016-03-19       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.